EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Oxymetazoline as a predictor of turbinate reduction surgery outcomes: Objective support from a prospective, single‐blinded, computational fluid dynamics study

Zachary T Root iD, Zhenxing Wu iD, Thomas J Lepley, Aspen R Schneller, Robbie J Chapman, Veronica L Formanek, Kathleen M Kelly, Bradley A Otto, Kai Zhao iD

International Forum of Allergy & Rhinology · 2024

DOI: 10.1002/alr.23422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2024. Verfasst von Zachary T Root und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Turbinates, Oxymetazoline, Nasal Decongestants, Nasal Obstruction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A patient's subjective response to topical nasal decongestant is often used to screen for turbinate reduction surgery suitability. However, this anecdotal strategy has not been objectively and quantitatively evaluated.

Methods

Prospective, longitudinal, and single‐blinded cohort study employing computational fluid dynamic modeling based on computed tomography scans at baseline, 30 min postoxymetazoline, and 2 months postsurgery on 11 patients with chronic turbinate hypertrophy.

Results

Nasal obstruction symptom evaluation (NOSE) and visual analogue scale (VAS) obstruction scores significantly improved from baseline to postoxymetazoline and again to postsurgery (NOSE: 71.82 ± 14.19 to 42.27 ± 25.26 to 22.27 ± 21.04; VAS: 6.09 ± 2.41 to 4.14 ± 2.20 to 2.08 ± 1.56; each interaction p < 0.05), with significant correlation between the latter two states ( r ∼0.37–0.69, p < 0.05). Oxymetazoline had a broader anatomical impact throughout inferior and middle turbinates than surgery (many p < 0.05); however, the improvement in regional airflow is similar (most p > 0.05) and predominantly surrounding the inferior turbinate. Strong postoxymetazoline to postsurgery correlations were observed in decreased nasal resistance ( r = 0.79, p < 0.05), increased regional airflow rates ( r = ‐0.47 to −0.55, p < 0.05) and regional air/mucosa shear force and heat flux ( r = 0.43 to 0.58, p < 0.05); however, only increasing peak heat flux significantly correlated to symptom score improvement (NOSE: r = 0.48, p < 0.05).

Conclusion

We present the first objective evidence that the “topical decongestant test” can help predict turbinate reduction surgery outcomes. The predictive effect is driven by similar improvementin regional airflow that leading to improved air/mucosa stimulations (peak heat flux) rather than through reduced nasal resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TurbinatesOxymetazolineNasal DecongestantsNasal ObstructionHumansMaleFemaleAdultMiddle AgedProspective StudiesSingle-Blind MethodTreatment OutcomeHydrodynamicsHypertrophyTomography, X-Ray Computed

Stichwörter der Autor:innen

adrenoceptor agonistcomputational fluid dynamics modelingoxymetazolineturbinate hypertrophyturbinate reductionα1 and α2‐adrenogeneic

Substanzen

OxymetazolineNasal Decongestants

Autor:innen und Institutionen

  • Department of Otolaryngology - Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA.

ORCID-Profile: Zachary T Root, Zhenxing Wu, Kai Zhao

Zitieren

APA

Root, Z. T., Wu, Z., Lepley, T. J., Schneller, A. R., Chapman, R. J., Formanek, V. L., Kelly, K. M., Otto, B. A., & Zhao, K. (2024). Oxymetazoline as a predictor of turbinate reduction surgery outcomes: Objective support from a prospective, single‐blinded, computational fluid dynamics study. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23422

Vancouver

Root ZT, Wu Z, Lepley TJ, Schneller AR, Chapman RJ, Formanek VL, et al. Oxymetazoline as a predictor of turbinate reduction surgery outcomes: Objective support from a prospective, single‐blinded, computational fluid dynamics study. International Forum of Allergy & Rhinology. 2024. doi:10.1002/alr.23422

BibTeX
@article{Root2024,
  author = {Root, Zachary T and Wu, Zhenxing and Lepley, Thomas J and Schneller, Aspen R and Chapman, Robbie J and Formanek, Veronica L and Kelly, Kathleen M and Otto, Bradley A and Zhao, Kai},
  title = {Oxymetazoline as a predictor of turbinate reduction surgery outcomes: Objective support from a prospective, single‐blinded, computational fluid dynamics study},
  journal = {International Forum of Allergy & Rhinology},
  year = {2024},
  doi = {10.1002/alr.23422}
}
Kostenlos starten →